Gilead Sciences Inc. has announced the appointment of Erin Burkhart as Senior Vice President, Controllership, and principal accounting officer, effective September 22, 2025. Burkhart joins Gilead from BioMarin Pharmaceutical Inc., where she has served as Group Vice President and Chief Accounting Officer since May 2022. She will succeed Diane E. Wilfong, who will step down from her interim role as Controller and principal accounting officer.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000882095-25-000035), on August 14, 2025, and is solely responsible for the information contained therein.